ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 161 filers reported holding ANIKA THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is 1.29 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $285,000 | -15.2% | 7,965 | +0.9% | 0.00% | – |
| Q3 2021 | $336,000 | -6.7% | 7,897 | -5.2% | 0.00% | – |
| Q2 2021 | $360,000 | +6.5% | 8,326 | +0.5% | 0.00% | – |
| Q1 2021 | $338,000 | -11.7% | 8,281 | -2.2% | 0.00% | – |
| Q4 2020 | $383,000 | +27.2% | 8,464 | -0.4% | 0.00% | – |
| Q3 2020 | $301,000 | +1.7% | 8,501 | 0.0% | 0.00% | – |
| Q2 2020 | $296,000 | +19.4% | 8,501 | -0.7% | 0.00% | – |
| Q1 2020 | $248,000 | -40.1% | 8,565 | +7.3% | 0.00% | – |
| Q4 2019 | $414,000 | -8.6% | 7,981 | -5.1% | 0.00% | -100.0% |
| Q3 2019 | $453,000 | +28.0% | 8,411 | -3.6% | 0.00% | – |
| Q2 2019 | $354,000 | -1.7% | 8,723 | -22.5% | 0.00% | – |
| Q2 2018 | $360,000 | -33.2% | 11,257 | +4.0% | 0.00% | -100.0% |
| Q1 2018 | $539,000 | -9.4% | 10,819 | -2.0% | 0.00% | 0.0% |
| Q4 2017 | $595,000 | -6.6% | 11,037 | +0.5% | 0.00% | 0.0% |
| Q3 2017 | $637,000 | +15.0% | 10,987 | -2.1% | 0.00% | 0.0% |
| Q2 2017 | $554,000 | +14.5% | 11,227 | +0.8% | 0.00% | 0.0% |
| Q1 2017 | $484,000 | +0.8% | 11,138 | +13.6% | 0.00% | 0.0% |
| Q4 2016 | $480,000 | +3.9% | 9,806 | +1.6% | 0.00% | 0.0% |
| Q3 2016 | $462,000 | -11.5% | 9,648 | -0.8% | 0.00% | 0.0% |
| Q2 2016 | $522,000 | +17.3% | 9,726 | -1.6% | 0.00% | – |
| Q1 2016 | $445,000 | +19.3% | 9,885 | +1.1% | 0.00% | – |
| Q4 2015 | $373,000 | +19.9% | 9,780 | 0.0% | 0.00% | – |
| Q3 2015 | $311,000 | -0.6% | 9,780 | +3.2% | 0.00% | – |
| Q2 2015 | $313,000 | -20.2% | 9,474 | -0.5% | 0.00% | – |
| Q1 2015 | $392,000 | +4.5% | 9,523 | +3.6% | 0.00% | -100.0% |
| Q4 2014 | $375,000 | +7.8% | 9,190 | -3.3% | 0.00% | 0.0% |
| Q3 2014 | $348,000 | -19.6% | 9,505 | +1.6% | 0.00% | 0.0% |
| Q2 2014 | $433,000 | +11.9% | 9,356 | -0.5% | 0.00% | 0.0% |
| Q1 2014 | $387,000 | +5.7% | 9,405 | -2.1% | 0.00% | 0.0% |
| Q4 2013 | $366,000 | +55.1% | 9,602 | -2.6% | 0.00% | – |
| Q3 2013 | $236,000 | +46.6% | 9,859 | +4.0% | 0.00% | – |
| Q2 2013 | $161,000 | – | 9,480 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Caligan Partners LP | 1,081,360 | $20,145,737 | 9.25% |
| Trigran Investments, Inc. | 2,217,019 | $41,303,065 | 4.40% |
| DIKER MANAGEMENT LLC | 50,239 | $935,953 | 0.84% |
| Virtus Investment Advisers, Inc. | 45,579 | $849,137 | 0.58% |
| Virtus Fund Advisers, LLC | 3,490 | $65,019 | 0.46% |
| CAPITAL MANAGEMENT CORP /VA | 84,225 | $1,569,112 | 0.35% |
| Riverwater Partners LLC | 17,597 | $327,832 | 0.30% |
| BOOTHBAY FUND MANAGEMENT, LLC | 617,602 | $11,505,925 | 0.27% |
| XTX Topco Ltd | 28,033 | $522,255 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 51,638 | $962 | 0.08% |